Scientists just found a cure for "bubble boy" disease, the rare genetic condition that severely weakens babies' immune systems. The therapy uses a modified virus to replace an infant's mutated genes with normal, functioning ones.
Unfortunately, a new proposal could hamper innovation like this.
The policy, called binding arbitration, would allow government-appointed officials to dictate what Medicare pays for certain drugs.